|ALUMINIUM FLUORIDE (ANHYDROUS)||ICSC: 1324 (June 2012)|
| CAS #: 7784-18-1
|EC Number: 232-051-1
|ACUTE HAZARDS||PREVENTION||FIRE FIGHTING|
|FIRE & EXPLOSION||Not combustible. Gives off irritating or toxic fumes (or gases) in a fire.||In case of fire in the surroundings, use appropriate extinguishing media.|
|PREVENT DISPERSION OF DUST!|
|Inhalation||Cough. Shortness of breath. Sore throat.||Use local exhaust or breathing protection.||Fresh air, rest. Refer for medical attention.|
|Skin||Pain. Redness.||Protective gloves.||Rinse skin with plenty of water or shower.|
|Eyes||Redness. Pain.||Wear safety goggles.||First rinse with plenty of water for several minutes (remove contact lenses if easily possible), then refer for medical attention.|
|Ingestion||Do not eat, drink, or smoke during work. Wash hands before eating.||Rinse mouth. Give one or two glasses of water to drink. Refer for medical attention .|
|SPILLAGE DISPOSAL||CLASSIFICATION & LABELLING|
|Personal protection: particulate filter respirator adapted to the airborne concentration of the substance. Sweep spilled substance into covered containers. If appropriate, moisten first to prevent dusting.||
According to UN GHS Criteria
|Dry. Well closed.|
|ALUMINIUM FLUORIDE (ANHYDROUS)||ICSC: 1324|
|PHYSICAL & CHEMICAL INFORMATION|
Physical State; Appearance
|EXPOSURE & HEALTH EFFECTS|
Routes of exposure
Effects of short-term exposure
Effects of long-term or repeated exposure
|OCCUPATIONAL EXPOSURE LIMITS|
TLV: (as F): 2.5 mg/m3, as TWA; A4 (not classifiable as a human carcinogen); BEI issued.
EU-OEL: (as F): 2,5 mg/m3 as TWA.
MAK: (as F, inhalable fraction): 1 mg/m3; peak limitation category: II(4); skin absorption (H); pregnancy risk group: C
|CAS 15098-87-0 and 32287-65-3 are for hydrated forms.
Temperature of decomposition is unknown in the literature.
The symptoms of asthma often do not become manifest until a few hours have passed and they are aggravated by physical effort. Rest and medical observation are therefore essential.
Anyone who has shown symptoms of asthma due to this substance should avoid all further contact.
|All rights reserved. The published material is being distributed without warranty of any kind, either expressed or implied. Neither ILO nor WHO nor the European Commission shall be responsible for the interpretation and use of the information contained in this material.|